Dem Unternehmen kann ich Phantasie beisprechen. Das neue Produkt wie mir mein Broker nannte soll der Renner werden. Vorsicht ist angesagt zum Zocken warum nicht.
Diese Info zu MBSC ist dir bestimmt bekannt.
MB SOFTWARE CORPORATION
Form 10-QSB
Quarter Ended March 31, 2001
INDEX
PART I - FINANCIAL INFORMATION PAGE NUMBER
Item 1 - Financial Statements
Consolidated Balance Sheets
March 31, 2001(Unaudited) and December 31, 2000 (Audited) 3-4
Consolidated Statements of Operations -
for the Three Months ended March 31, 2001(Unaudited) and
March 31, 2000 (Unaudited) 5
Consolidated Statements of Cash Flows
for the Three Months ended March 31, 2001(Unaudited)
and March 31, 2000 (Unaudited) 6
Notes to Consolidated Financial Statements 7
Item 2 - Management's Discussion
and Analysis of Financial Condition and
Results of Operations 7-8
PART II - OTHER INFORMATION
Item 5 - Other Information 9
Item 6 - Exhibits, Financial Statement Schedules
and Reports on Form 8-K 9
SIGNATURES 9
2
--------------------------------------------------
MB SOFTWARE CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
ASSETS
March 31, December 31,
2001 2000
----------- ----------
(Unaudited) (Audited)
CURRENT ASSETS
Cash $ -- $ 29,910
Medical receivables, net allowance 681,339 525,265
for doubtful accounts and contactual
allowances of $1,118,630 and $1,118,630 in 2001 and
2000, respectively
Notes receivable 15,722 --
Prepaid expenses 7,788 25,049
---------- ----------
Total Current Assets 704,849 580,224
---------- ----------
PROPERTY AND EQUIPMENT, NET 106,414 116,127
---------- ----------
Note receivable - shareholder 350,000 350,000
Employee advances 90,000 90,000
---------- ----------
Total Assets $1,251,263 $1,136,351
========== ==========
The Notes to the Consolidated Financial Statements are an integral part of these statements.
3
--------------------------------------------------
MB SOFTWARE CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
LIABILITIES AND SHAREHOLDERS' DEFICIT
March 31, December 31,
2001 2000
---------- ---------
(Unaudited) (Audited)
CURRENT LIABILITIES
Outstanding check in excess of bank balances $ 14,083 $ --
Notes payable 1,766,820 1,658,870
Current maturities of capital leases -- 1,494
Accounts payable 363,527 354,803
Accrued liabilities 490,402 500,120
--------- ---------
Total current liabilities 2,634,832 2,515,287
--------- ---------
Total long term liabilities -- --
--------- ---------
TOTAL LIABILITIES 2,634,832 2,515,287
SHAREHOLDERS' DEFICIT
Series A senior cumulative convertible particpating preferred
stock; $10 par value; 340,000 shares issued and outstanding
in 2000 and 1999; dividends in arrears 2000 $810,644, and 3,400,000 3,400,000
1999, $385,644
Undesignated preferred stock; $10 par value; 660,000 shares
authorized; none issued -- --
Common stock .001 par value;150,000,000 shares
authorized; 70,400,000 and 70,300,000 shares 70,400 70,300
issued in 2001 and 2000, respectively
Additional paid-in capital 1,453,082 1,434,431
Accumulated deficit (6,068,405) (6,039,162)
Deferred license and consulting cost, net (226,607) (232,466)
--------- ---------
(1,371,530) (1,366,897)
Treasury stock, at cost; 408,029 shares (12,039) (12,039)
--------- ---------
Total shareholders' deficit (1,383,569) (1,378,936)
--------- ---------
TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT $1,251,263 $1,136,351
========= =========
The Notes to the Consolidated Financial Statements are an integral part of these statements.
4
--------------------------------------------------
MB SOFTWARE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)
Three Months Ended
March 31, 2001 March 31, 2000
REVENUES
Medical income - net of contractual
Adjustments of $353,063 and $361,822
in 2001 and 2000, respectively $ 681,946 $ 688,926
Service fees 136
------------ ------------
Total revenues 681,946 689,062
COST OF REVENUES
Cost of medical services 293,882 392,692
------------ ------------
Total cost of revenues 293,882 392,692
------------ ------------
GROSS PROFIT 388,064 296,370
OPERATING EXPENSES
Selling, general & administrative 368,571 287,402
Depreciation and amortization 20,509 13,705
------------ ------------
Total operating expenses 389,080 301,107
OTHER INCOME (EXPENSE)
Interest income and other 7,011 --
Other expense -- 9,644
Interest Expense (35,237) (30,920)
------------ ------------
Total other income (expense) (28,226) (21,276)
------------ ------------
NET LOSS $ (29,243) $ (26,013)
============ ============
Plus: Cumulative preferred stock dividends 85,000 85,000
------------ ------------
Income (loss) available to common shareholders $ (114,243) $ (111,013)
============ ============
BASIC AND DILUTED EARNINGS (L0SS) PER SHARE (0.00) (0.00)
============ ============
Weighted-average common shares outstanding 70,400,000 69,200,000
============ ============
Cumulative preferred dividends per share $ -- $ --
============ ============
The Notes to the Consolidated Financial Statements are an integral part of these statements.
5
--------------------------------------------------
MB SOFTWARE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
THREE MONTHS THREE MONTHS
ENDED 03/31/01 ENDED 03/31/00
2001 2000
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss from continuing operations $ (29,243) $ (26,013)
Adjustments to reconcile net loss from continuing
operations to cash used by operating activities:
Depreciation 14,650 13,706
Consulting costs recognized 24,610
Change in allowance for doubtfull accounts -- 24,716
Changes in assets and liabilities:
Accounts receivable (156,074) (171,684)
Accounts payable 8,724 (76,864)
Accrued liabilities (9,718) (12,038)
Outstanding checks in excess of bank balances 14,083 101,860
Prepaid expenses 17,261
--------- ---------
Net cash used in operating activities (115,707) (146,317)
CASH FLOWS FROM INVESTING ACTIVITIES
Borrowing (payments) on note receivables (15,722) 10,087
Purchase of fixed assets (4,938) --
--------- ---------
Net cash provided by investing activities (20,660) 10,087
CASH FLOWS FROM FINANCING ACTIVITIES
Payments on capital leases (1,493) (13,848)
Payments on notes payable -- --
Proceeds from new borrowings 107,950 79,000
Proceeds from notes payable related parties -- 45,000
--------- ---------
Net cash provided by financing activities 106,457 110,152
--------- ---------
NET DECREASE IN CASH (29,910) (26,078)
Cash at beginning of period 29,910 26,078
--------- ---------
Cash at end of period $ -- $ --
========= =========
SUPPLEMENTAL INFORMATION
Cash paid during the period for interest to related party -- --
Cash paid during the period for interest to others $ 44,955 $ 30,920
--------- ---------
$ 44,955 $ 30,920
========= =========
The Notes to the Consolidated Financial Statements are an integral part of these statements.
6
--------------------------------------------------
NOTE 1: BASIS OF PRESENTATION
The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-QSB and Rule 10-01 of Regulations S-X. They do not include all information and notes required by generally accepted accounting principles for complete financial statements. However, except as disclosed, there has been no material change in the information disclosed in the notes to consolidated financial statements included in the Annual Report on Form 10-KSB of MB Software Corporation ( the Company) for the year ended December 31, 2000 In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included in the Operating results for the three month period ended March 31, 2001 and are not necessarily indicative of the results that may be expected for the year ending December 31, 2001.
NOTE 2: ORGANIZATION AND NATURE OF OPERATIONS
The financial statements have been prepared on a going concern basis, which contemplates realization of assets and liquidation of liabilities in the ordinary course of business. The Company has continuously incurred losses from operations and has a working capital deficit. The appropriateness of using the going concern basis is dependent upon the Company's ability to obtain additional financing or equity capital and, ultimately, to achieve profitable operations. These conditions raise substantial doubt about its ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Management plans to raise capital by obtaining financing through debt private placement or conversion of Series A preferred stock. The Company believes that these actions will enable the Company to continue until its operations become profitable.
NOTE 3: RELATED PARTIES
Included in notes payable is related party payables of $1,766,820 and $1,181,925 for 2001 and 2000, respectively.
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
In the first quarter of 2001, the Company continued to focus on the development and distribution of PatientMed 2000, an Internet appliance. The Company has also continued operations of its healthcare clinics. These clinics include three Company-owned physician practices in Florida that focus primarily on pain management and the sale of nutritional supplements. To unify the clinics and the Internet appliance, the Company has developed a healthcare Internet site, HealthcareInnovations.net. The site is dedicated to pain management programs for patients and the sale of the nutritional supplements.
There were no changes in the legal proceedings from the status set forth in the Form 10 - KSB for the year ending December 31, 2000.
7
--------------------------------------------------
Three Months Ended March 31,2001 Compared to Three Months Ended March 31, 2000
Net medical revenues decreased .010% to $681,946 for the three months ended March 31, 2001 as compared to $688,926 for the three months ended March 31, 2000. This relative stability reflects, in part, the success of administrative changes instituted in the prior year.
The contractual allowance adjustment decreased 2.4 % to $353,053 for the first quarter of 2001 compared with $361,822 for the three months ended March 31, 2000. The contractual allowance adjustment reflects a reduction in revenue resulting from uncollectible accounts together with contractual allowances for reductions, due to the source of payments. Again, this relative stability reflects the success of the administrative restructuring commenced during year 2000.
The cost of medical revenues decreased 25% to $293,882 for the three months ended March 31, 2001 compared to $392,692 for the three months ended March 31, 2000. The decrease in cost is attributable, in part, to increased purchasing efficiency as well as the reduction of costs associated with the elimination of the Lauderhill clinic during the year 2000.
The gross profit from medical activities increased 31% to $388,064 for the three months ended March 31, 2001 as compared to $296,370 for the three months ended March 31, 2000. This increase in gross profit from medical activities directly reflects increased operating efficiency in accordance with the Company's overall strategy for the clinics.
The selling, general and administrative expenses increased by 28% to $368,571 for the three-month period ended March 31, 2001 as compared to $287,402 for the three-month period ended March 31, 2001. This increase reflects the costs attendant to the start-up expenses for PatientMed2000(TM).
The net loss from continuing operations increased to ($29,243) for the three-month period ended March 31, 2001, as compared to a loss from continuing operations of ($26, 013) for the three months ended March 31, 2000. This figure additionally reflects the relative success of the Company in stabilizing and streamlining Company operations.
Liquidity and Capital Resources
The Company's operations used $115,707 of cash during the three months ended March 31, 2001 compared to a use of cash of $146,317 for the quarter ended March 31,2000.
As of March 31, 2001, the Company had working capital deficits of $1,929,983. The working capital as of March 31, 2000 was $1,935,063. At March 31, 2001, the Company had outstanding checks in excess of bank balances of $14,083. To increase working capital, the Company is concentrating its efforts to distribute volume units of PatientMed2000(TM) while contemporaneously increasing patient revenue at the Florida clinics. The Internet site is expected to unify these twin goals by providing Internet advertising for the clinics and the Internet.
In the three months ended March 31, 2001, the Company had no expenditures for the purchase of equipment of $4,938. The Company does not anticipate any major purchase of equipment for the remaining nine (9) months of 2001.
8
--------------------------------------------------
PART II - OTHER INFORMATION
ITEM 5. OTHER INFORMATION
None
ITEM 6. EXHIBITS, FINANCIAL STATEMENT SCHEDULES AND REPORTS ON FORM 8-K
Exhibits - All exhibits are incorporated by reference from prior filings with the Commission.
Financial Statements - See Item 1 for financial statements filed with this report.
Reports on Form 8-K - None
SIGNATURES
In accordance with the requirements of the Securities Exchange Act, the registrant has caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
MB SOFTWARE CORPORATION
Date: May 11,2001 /s/ Scott A. Haire
------------------
Scott A. Haire, Chairman of the Board,
Chief Executive Officer and President
(Principal Financial Officer)
Diese Info zu MBSC ist dir bestimmt bekannt.
MB SOFTWARE CORPORATION
Form 10-QSB
Quarter Ended March 31, 2001
INDEX
PART I - FINANCIAL INFORMATION PAGE NUMBER
Item 1 - Financial Statements
Consolidated Balance Sheets
March 31, 2001(Unaudited) and December 31, 2000 (Audited) 3-4
Consolidated Statements of Operations -
for the Three Months ended March 31, 2001(Unaudited) and
March 31, 2000 (Unaudited) 5
Consolidated Statements of Cash Flows
for the Three Months ended March 31, 2001(Unaudited)
and March 31, 2000 (Unaudited) 6
Notes to Consolidated Financial Statements 7
Item 2 - Management's Discussion
and Analysis of Financial Condition and
Results of Operations 7-8
PART II - OTHER INFORMATION
Item 5 - Other Information 9
Item 6 - Exhibits, Financial Statement Schedules
and Reports on Form 8-K 9
SIGNATURES 9
2
--------------------------------------------------
MB SOFTWARE CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
ASSETS
March 31, December 31,
2001 2000
----------- ----------
(Unaudited) (Audited)
CURRENT ASSETS
Cash $ -- $ 29,910
Medical receivables, net allowance 681,339 525,265
for doubtful accounts and contactual
allowances of $1,118,630 and $1,118,630 in 2001 and
2000, respectively
Notes receivable 15,722 --
Prepaid expenses 7,788 25,049
---------- ----------
Total Current Assets 704,849 580,224
---------- ----------
PROPERTY AND EQUIPMENT, NET 106,414 116,127
---------- ----------
Note receivable - shareholder 350,000 350,000
Employee advances 90,000 90,000
---------- ----------
Total Assets $1,251,263 $1,136,351
========== ==========
The Notes to the Consolidated Financial Statements are an integral part of these statements.
3
--------------------------------------------------
MB SOFTWARE CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
LIABILITIES AND SHAREHOLDERS' DEFICIT
March 31, December 31,
2001 2000
---------- ---------
(Unaudited) (Audited)
CURRENT LIABILITIES
Outstanding check in excess of bank balances $ 14,083 $ --
Notes payable 1,766,820 1,658,870
Current maturities of capital leases -- 1,494
Accounts payable 363,527 354,803
Accrued liabilities 490,402 500,120
--------- ---------
Total current liabilities 2,634,832 2,515,287
--------- ---------
Total long term liabilities -- --
--------- ---------
TOTAL LIABILITIES 2,634,832 2,515,287
SHAREHOLDERS' DEFICIT
Series A senior cumulative convertible particpating preferred
stock; $10 par value; 340,000 shares issued and outstanding
in 2000 and 1999; dividends in arrears 2000 $810,644, and 3,400,000 3,400,000
1999, $385,644
Undesignated preferred stock; $10 par value; 660,000 shares
authorized; none issued -- --
Common stock .001 par value;150,000,000 shares
authorized; 70,400,000 and 70,300,000 shares 70,400 70,300
issued in 2001 and 2000, respectively
Additional paid-in capital 1,453,082 1,434,431
Accumulated deficit (6,068,405) (6,039,162)
Deferred license and consulting cost, net (226,607) (232,466)
--------- ---------
(1,371,530) (1,366,897)
Treasury stock, at cost; 408,029 shares (12,039) (12,039)
--------- ---------
Total shareholders' deficit (1,383,569) (1,378,936)
--------- ---------
TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT $1,251,263 $1,136,351
========= =========
The Notes to the Consolidated Financial Statements are an integral part of these statements.
4
--------------------------------------------------
MB SOFTWARE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)
Three Months Ended
March 31, 2001 March 31, 2000
REVENUES
Medical income - net of contractual
Adjustments of $353,063 and $361,822
in 2001 and 2000, respectively $ 681,946 $ 688,926
Service fees 136
------------ ------------
Total revenues 681,946 689,062
COST OF REVENUES
Cost of medical services 293,882 392,692
------------ ------------
Total cost of revenues 293,882 392,692
------------ ------------
GROSS PROFIT 388,064 296,370
OPERATING EXPENSES
Selling, general & administrative 368,571 287,402
Depreciation and amortization 20,509 13,705
------------ ------------
Total operating expenses 389,080 301,107
OTHER INCOME (EXPENSE)
Interest income and other 7,011 --
Other expense -- 9,644
Interest Expense (35,237) (30,920)
------------ ------------
Total other income (expense) (28,226) (21,276)
------------ ------------
NET LOSS $ (29,243) $ (26,013)
============ ============
Plus: Cumulative preferred stock dividends 85,000 85,000
------------ ------------
Income (loss) available to common shareholders $ (114,243) $ (111,013)
============ ============
BASIC AND DILUTED EARNINGS (L0SS) PER SHARE (0.00) (0.00)
============ ============
Weighted-average common shares outstanding 70,400,000 69,200,000
============ ============
Cumulative preferred dividends per share $ -- $ --
============ ============
The Notes to the Consolidated Financial Statements are an integral part of these statements.
5
--------------------------------------------------
MB SOFTWARE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
THREE MONTHS THREE MONTHS
ENDED 03/31/01 ENDED 03/31/00
2001 2000
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss from continuing operations $ (29,243) $ (26,013)
Adjustments to reconcile net loss from continuing
operations to cash used by operating activities:
Depreciation 14,650 13,706
Consulting costs recognized 24,610
Change in allowance for doubtfull accounts -- 24,716
Changes in assets and liabilities:
Accounts receivable (156,074) (171,684)
Accounts payable 8,724 (76,864)
Accrued liabilities (9,718) (12,038)
Outstanding checks in excess of bank balances 14,083 101,860
Prepaid expenses 17,261
--------- ---------
Net cash used in operating activities (115,707) (146,317)
CASH FLOWS FROM INVESTING ACTIVITIES
Borrowing (payments) on note receivables (15,722) 10,087
Purchase of fixed assets (4,938) --
--------- ---------
Net cash provided by investing activities (20,660) 10,087
CASH FLOWS FROM FINANCING ACTIVITIES
Payments on capital leases (1,493) (13,848)
Payments on notes payable -- --
Proceeds from new borrowings 107,950 79,000
Proceeds from notes payable related parties -- 45,000
--------- ---------
Net cash provided by financing activities 106,457 110,152
--------- ---------
NET DECREASE IN CASH (29,910) (26,078)
Cash at beginning of period 29,910 26,078
--------- ---------
Cash at end of period $ -- $ --
========= =========
SUPPLEMENTAL INFORMATION
Cash paid during the period for interest to related party -- --
Cash paid during the period for interest to others $ 44,955 $ 30,920
--------- ---------
$ 44,955 $ 30,920
========= =========
The Notes to the Consolidated Financial Statements are an integral part of these statements.
6
--------------------------------------------------
NOTE 1: BASIS OF PRESENTATION
The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-QSB and Rule 10-01 of Regulations S-X. They do not include all information and notes required by generally accepted accounting principles for complete financial statements. However, except as disclosed, there has been no material change in the information disclosed in the notes to consolidated financial statements included in the Annual Report on Form 10-KSB of MB Software Corporation ( the Company) for the year ended December 31, 2000 In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included in the Operating results for the three month period ended March 31, 2001 and are not necessarily indicative of the results that may be expected for the year ending December 31, 2001.
NOTE 2: ORGANIZATION AND NATURE OF OPERATIONS
The financial statements have been prepared on a going concern basis, which contemplates realization of assets and liquidation of liabilities in the ordinary course of business. The Company has continuously incurred losses from operations and has a working capital deficit. The appropriateness of using the going concern basis is dependent upon the Company's ability to obtain additional financing or equity capital and, ultimately, to achieve profitable operations. These conditions raise substantial doubt about its ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Management plans to raise capital by obtaining financing through debt private placement or conversion of Series A preferred stock. The Company believes that these actions will enable the Company to continue until its operations become profitable.
NOTE 3: RELATED PARTIES
Included in notes payable is related party payables of $1,766,820 and $1,181,925 for 2001 and 2000, respectively.
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
In the first quarter of 2001, the Company continued to focus on the development and distribution of PatientMed 2000, an Internet appliance. The Company has also continued operations of its healthcare clinics. These clinics include three Company-owned physician practices in Florida that focus primarily on pain management and the sale of nutritional supplements. To unify the clinics and the Internet appliance, the Company has developed a healthcare Internet site, HealthcareInnovations.net. The site is dedicated to pain management programs for patients and the sale of the nutritional supplements.
There were no changes in the legal proceedings from the status set forth in the Form 10 - KSB for the year ending December 31, 2000.
7
--------------------------------------------------
Three Months Ended March 31,2001 Compared to Three Months Ended March 31, 2000
Net medical revenues decreased .010% to $681,946 for the three months ended March 31, 2001 as compared to $688,926 for the three months ended March 31, 2000. This relative stability reflects, in part, the success of administrative changes instituted in the prior year.
The contractual allowance adjustment decreased 2.4 % to $353,053 for the first quarter of 2001 compared with $361,822 for the three months ended March 31, 2000. The contractual allowance adjustment reflects a reduction in revenue resulting from uncollectible accounts together with contractual allowances for reductions, due to the source of payments. Again, this relative stability reflects the success of the administrative restructuring commenced during year 2000.
The cost of medical revenues decreased 25% to $293,882 for the three months ended March 31, 2001 compared to $392,692 for the three months ended March 31, 2000. The decrease in cost is attributable, in part, to increased purchasing efficiency as well as the reduction of costs associated with the elimination of the Lauderhill clinic during the year 2000.
The gross profit from medical activities increased 31% to $388,064 for the three months ended March 31, 2001 as compared to $296,370 for the three months ended March 31, 2000. This increase in gross profit from medical activities directly reflects increased operating efficiency in accordance with the Company's overall strategy for the clinics.
The selling, general and administrative expenses increased by 28% to $368,571 for the three-month period ended March 31, 2001 as compared to $287,402 for the three-month period ended March 31, 2001. This increase reflects the costs attendant to the start-up expenses for PatientMed2000(TM).
The net loss from continuing operations increased to ($29,243) for the three-month period ended March 31, 2001, as compared to a loss from continuing operations of ($26, 013) for the three months ended March 31, 2000. This figure additionally reflects the relative success of the Company in stabilizing and streamlining Company operations.
Liquidity and Capital Resources
The Company's operations used $115,707 of cash during the three months ended March 31, 2001 compared to a use of cash of $146,317 for the quarter ended March 31,2000.
As of March 31, 2001, the Company had working capital deficits of $1,929,983. The working capital as of March 31, 2000 was $1,935,063. At March 31, 2001, the Company had outstanding checks in excess of bank balances of $14,083. To increase working capital, the Company is concentrating its efforts to distribute volume units of PatientMed2000(TM) while contemporaneously increasing patient revenue at the Florida clinics. The Internet site is expected to unify these twin goals by providing Internet advertising for the clinics and the Internet.
In the three months ended March 31, 2001, the Company had no expenditures for the purchase of equipment of $4,938. The Company does not anticipate any major purchase of equipment for the remaining nine (9) months of 2001.
8
--------------------------------------------------
PART II - OTHER INFORMATION
ITEM 5. OTHER INFORMATION
None
ITEM 6. EXHIBITS, FINANCIAL STATEMENT SCHEDULES AND REPORTS ON FORM 8-K
Exhibits - All exhibits are incorporated by reference from prior filings with the Commission.
Financial Statements - See Item 1 for financial statements filed with this report.
Reports on Form 8-K - None
SIGNATURES
In accordance with the requirements of the Securities Exchange Act, the registrant has caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
MB SOFTWARE CORPORATION
Date: May 11,2001 /s/ Scott A. Haire
------------------
Scott A. Haire, Chairman of the Board,
Chief Executive Officer and President
(Principal Financial Officer)
